zPREDICTA YCアプリケーション

Summer 2015Acquired

zPREDICTAはSummer 2015バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Summer 2015
業界: HealthcareDrug Discovery and Delivery
チーム規模: 2
ステータス: Acquired
ローンチ済み: 2015

創業者

Mukti ParikhFounder/CTO

zPREDICTAの事業内容

zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.

zPREDICTAのYCアプリケーション、再構築済み

Y Combinator 申請

zPREDICTA 様、Summer 2015 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

zPREDICTA

Describe what your company does in 50 characters or less.

Patient-derived 3D tissue models for drug testing

What is your company going to make? Please describe your product and what it does or will do.

We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.

Where do you live now, and where would the company be based after YC?

We live in San Jose, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

zPREDICTAの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、zPREDICTAの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。zPREDICTAのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。